Verrica Pharmaceuticals's three largest insider shareholders as of August 04, 2026 are Paul B Manning (Director, 7.31Mn shares), Advisors Llc Perceptive (TenPercentOwner, 7.10Mn shares), John A Iii Stalfort (Director, 1.87Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Advisors Llc Perceptive | - | 0 | 7,099,182 | 29 Dec, 2023 |
| Paul B Manning | - | 3,958,189 | 3,348,372 | 25 Nov, 2025 |
| John J. Kirby | Interim Cfo | 18,962 | 0 | 30 Dec, 2025 |
| Noah L. Rosenberg | Cmo | 2,357 | 0 | 25 Nov, 2025 |
| John A Iii Stalfort | - | 1,873,800 | 0 | 26 Nov, 2024 |
| Gary Goldenberg | Chief Medical Officer | 94,261 | 0 | 28 Aug, 2024 |
| Ted White | President And Ceo | 215,967 | 0 | 28 Aug, 2024 |
| Joe Bonaccorso | Chief Commercial Officer | 73,114 | 0 | 28 Aug, 2024 |
| Christopher G. Hayes | Chief Legal Officer | 176,458 | 0 | 18 Mar, 2025 |
| Terry Kohler | Chief Financial Officer | 44,697 | 0 | 28 Aug, 2024 |
| Jayson Rieger | Ceo And President | 182,593 | 0 | 25 Nov, 2025 |
| David Zawitz | Chief Operating Officer | 21,000 | 0 | 25 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Dec, 2025 | John J. Kirby | Common Stock | A | 10,000 | $0.00 | 18,962 | D | A |
| 25 Nov, 2025 | Noah L. Rosenberg | Common Stock | A | 2,357 | $4.24 | 2,357 | D | P |
| 25 Nov, 2025 | Jayson Rieger | Common Stock | A | 94,311 | $4.24 | 182,593 | D | P |
| 25 Nov, 2025 | David Zawitz | Common Stock | A | 10,000 | $4.24 | 21,000 | D | P |
| 25 Nov, 2025 | Paul B Manning | Common Stock | A | 1,375,380 | $4.24 | 3,958,189 | D | P |
| 25 Nov, 2025 | John J. Kirby | Common Stock | A | 3,536 | $4.24 | 8,962 | D | P |
| 25 Nov, 2025 | David Zawitz | Common Stock | A | 10,000 | $4.24 | 21,000 | D | P |
| 25 Nov, 2025 | David Zawitz | Common Stock | A | 10,000 | $4.24 | 21,000 | D | P |
| 25 Nov, 2025 | John J. Kirby | Series C Warrant (right to buy) | A | 884 | - | 884 | D | P |
| 25 Nov, 2025 | David Zawitz | Series C Warrant (right to buy) | A | 2,500 | - | 2,500 | D | P |
| 25 Nov, 2025 | Paul B Manning | Common Stock | A | 2,750,762 | $4.24 | 3,348,372 | I | P |
| 25 Nov, 2025 | Noah L. Rosenberg | Series C Warrant (right to buy) | A | 589 | - | 589 | D | P |
| 25 Nov, 2025 | David Zawitz | Series C Warrant (right to buy) | A | 2,500 | - | 2,500 | D | P |
| 25 Nov, 2025 | David Zawitz | Series C Warrant (right to buy) | A | 2,500 | - | 2,500 | D | P |
| 25 Nov, 2025 | Jayson Rieger | Series C Warrant (right to buy) | A | 23,577 | - | 23,577 | D | P |
| 25 Nov, 2025 | Paul B Manning | Series C Warrant (right to buy) | A | 343,845 | - | 343,845 | D | P |
| 25 Nov, 2025 | Paul B Manning | Series C Warrant (right to buy) | A | 687,690 | - | 687,690 | I | P |
| 05 Jun, 2025 | Lawrence Eichenfield | Stock Option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 05 Jun, 2025 | Gavin Corcoran | Stock Option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 05 Jun, 2025 | Diem Nguyen | Stock Option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |